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Background: The mechanisms connecting dietary intake of processed foods with
systemic inflammatory markers and cardiovascular risk remain poorly defined. We
sought to compare the abundance of pro-inflammatory stimulants of innate immune
receptors in processed foods with those produced by the murine ileal and caecal
microbiota, and to explore the impact of their ingestion on systemic inflammation and
lipid metabolism in vivo.
Methods and results: Calibrated receptor-dependent reporter assays revealed
that many processed foods, particularly those based on minced meats, contain
pro-inflammatory stimulants of Toll-like receptor (TLR)-2 and TLR4 at concentrations
which greatly exceed those produced by the endogenous murine ileal microbiota.
Chronic dietary supplementation with these stimulants, at concentrations relevant to
those measured in theWestern diet, promoted hepatic inflammation and reduced several
markers of reverse cholesterol transport (RCT) in mice. Hepatocytes were found to
be insensitive to TLR2- and TLR4-stimulants directly, but their secretion of functional
cholesterol acceptors was impaired by interleukin (IL)-1β released by TLR-responsive
hepatic macrophages. Hepatic macrophage priming by high-fat diet enhanced the
impairment of RCT by ingested endotoxin, and this was reversed by macrophage
depletion via clodronate liposome treatment, or genetic deficiency in the IL-1 receptor.
Conclusion: These findings reveal an unexpected mechanism connecting processed
food consumption with cardiovascular risk factors, and introduce the food microbiota as
a potential target for therapeutic regulation of lipid metabolism.
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INTRODUCTION
Atherosclerosis is a chronic inflammatory disease of the arteries that represents the root cause
of the majority of cardiovascular diseases (1). Diet, inflammation and lipid metabolism are
well-established risk factors for this disease. However, potential mechanisms linking these factors
remain to be clearly defined. In particular, the mechanisms by which adherence to the Western
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dietary pattern increases circulating inflammatory markers and
risk of coronary artery disease (CAD), relative to prudent diets,
remain poorly understood (2, 3). Evidence from murine models
of diet-induced atherosclerosis suggests that inflammation
triggered via the innate immune receptors Toll-like receptor
(TLR)-2 and TLR4 is likely to be involved (4, 5). However,
the stimuli responsible for the triggering of atherogenic TLR-
signaling, and how these may relate to diet, lipid metabolism or
CAD risk, remain to be established.
In earlier work, we found that many processed foods
trigger inflammatory signaling in human monocytes in vitro
in a manner dependent on food content of the canonical
ligands of TLR2 and TLR4 (namely bacterial lipopeptides and
lipopolysaccharides, LPS), which are introduced into foods by
common, non-pathogenic food spoilage bacteria (6, 7). Human
feeding studies then showed that the consumption of diets rich in
these TLR-stimulants increased several markers of cardiovascular
risk, including low-density lipoprotein (LDL)-cholesterol, and
inflammatory markers, relative to a low TLR-stimulant run-in
diet (8). Likewise, nutritionally identical meals differing only
in content of bacterial molecules had opposing effects on the
post-prandial induction of leukocyte inflammatory markers (8).
However, these findings were difficult to explain, since
the human commensal microbiota comprises ∼100 trillion
bacteria, and a burden of pro-inflammatory pathogen-associated
molecular patterns (PAMPs) that presumably far exceeds that
contained in the diet (9, 10). Enterocytes are also reported to
be largely unresponsive to apical TLR-stimulants, and when
their intracellular or basolateral TLRs are triggered, a barrier
enhancing effect, rather than an inflammatory response, is
typically induced (11, 12). Systemic absorption of appreciable
quantities of dietary PAMPs is also considered to be unlikely,
as earlier studies demonstrated extremely low or undetectable
uptake of ingested endotoxin to serum, and no obvious pathology
in LPS feeding studies (13, 14). In light of these observations,
which are presumed to reflect adaptations which limit host
inflammatory responses to the commensal microbiota, it is not
clear how dietary TLR-stimulants, ingested at doses far lower
than thought to be present in the intestine, could alter systemic
inflammatory tone, or lipoprotein metabolism.
We therefore aimed to revisit these assumptions using a
variety of approaches to PAMP quantitation and tracking.
Potential mechanisms connecting dietary PAMP intake with
systemic inflammatory signaling and lipid metabolism were
then explored using genetic and pharmacological approaches in
murine models of dietary PAMP supplementation.
Abbreviations: ApoAI, Apolipoprotein AI; APR, Acute phase response; CAD,
Coronary artery disease; iEDAP, D-gamma-Glu-meso-diaminopimelic acid;
GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; HBSS, Hank’s balanced salt
solution; HOMA-IR, Homeostatic model assessment of insulin resistance; KC,
Kupffer cell; LAL, Limulus amoebocyte lysate; LPS, Lipopolysaccharide; NAFLD,
Non-alcoholic fatty liver disease; NOD, Nucleotide-binding oligomerization
domain-containing protein; OxPAPC, Oxidized palmitoyl arachidonyl
phosphatidyl choline; PAMP, Pathogen-associated molecular pattern; PBMC,
Peripheral blood mononuclear cells; RCT, Reverse cholesterol transport; rDNA,
Bacterial 16S ribosome gene DNA; SAA, Serum amyloid A; SPF, Specific pathogen
free; TLR, Toll-like receptor; TNF, Tumor necrosis factor.
METHODS
Mice
Wild-type (WT) C57BL/6, and Il1r1−/− mice fully backcrossed
onto the C57BL/6 line, were purchased from Charles River (UK)
and used after 7 days acclimatization at the University of Leicester
specific pathogen free (SPF) animal housing facility, or bred
within the facility for use in experiments from 7 weeks of age.
Genotype was confirmed by PCR. Male mice were used for
all experiments to limit the potential impact of estrous cycle
on inflammatory markers. Diets used were normal (low-fat)
mouse chow (TestDiet, 5LF2), high fat diet (TestDiet, 5TJN)
and high cholesterol diet (TestDiet, 5TJT). Mice were randomly
allocated to control or PAMP treatment by technicians blinded
to experimental outcomes, and littermates were generally split to
receive both treatments. All mouse experiments were conducted
according to Home Office guidelines and with institutional and
Home Office approval (PPL60/4332).
Human Subjects
Peripheral blood mononuclear cells (PBMC) were prepared from
venous blood collected by venepuncture from healthy human
volunteers with informed, written consent (age 22–35 years, n
= 7, all male) according to the guidelines laid down in the
Declaration of Helsinki and with approval from the University
of Leicester College of Medicine Research Ethics Committee.
Exclusion criteria included self-reporting of a previous diagnosis
of any chronic inflammatory disease (such as arthritis or
inflammatory bowel disease), infection within the previous 4
weeks or use of any medication other than oral contraceptives
within the last week.
Preparation of Food and
Microbiota Extracts
Foods from three major categories previously identified to be
at high risk of containing elevated levels of PAMPs [minced
meat, diced onion, and chocolate containing products (6)] were
purchased from local supermarkets. Extracts were prepared by
homogenizing 25 g of each product in 250ml phosphate buffered
saline (PBS). The samples were then clarified by centrifugation
(13,000 g for 5min) and the resulting supernatant was filter-
sterilized (0.22µm, low-protein binding filters, Acrodisc). This
step was taken to prevent the growth of microbes during tissue
culture, which would interfere with TLR-stimulant quantitation,
and also to represent the free, soluble PAMPs present in each
sample, since these are more likely to be absorbed from the
gut lumen than PAMPs which remain attached to or within
bacterial cells. Samples were stored at −20◦C before batch assay
for TLR-stimulant content. Human and murine stool samples
were collected with informed consent and institutional ethical
approval and were processed in the same way.
Quantification of TLR-Stimulants
We focused specifically on quantitation of stimulants of TLR2
and TLR4 in this project because inflammatory cytokine
production by food extracts was found to be dependent
predominantly on signaling via these two receptors, and because
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both receptors play key roles in murine atherogenesis (4, 5). TLR-
stimulants were quantified in aqueous extracts of food, stool or
ileal content samples using a HEK-293 TLR-transfection assay
as described previously (6). Briefly, HEK-293 cells cultured in
96 well plates were transfected with plasmids coding for the
following genes: human (h)TLR2, hTLR4 (co-expressing hMD-2)
or hTLR5 (each 30 ng, Invivogen), hCD14 (30 ng), thymidine-
kinase promoter driven renilla reporter (internal transfection
efficiency control, 10 ng) and NF-κB-sensitive luciferase-reporter
(10 ng). Cells were grown for 3 days post transfection prior to 18 h
challenge with extracts diluted 1:10 inDulbecco’sModified Eagles
Medium (DMEM) / 1% Fetal Calf Serum (FCS). Standard curves
were prepared in all sample measurement plates using serial
dilutions of Pam3CSK4, E. coli LPS or S. typhimurium flagellin.
NF-κB reporter expression was calculated as fold induction
relative to cells cultured in medium alone, and compared with
the standard curve to yield the biological activities of each type of
TLR-stimulant in the samples, relative to the respective standard.
As transfected cells were sensitive to a minimum of 0.1 ng/ml
LPS or Pam3CSK4, the minimum concentration of food-borne
PAMPs detectable by the assay was 10 ng LPS- or Pam3CSK4-
equivalents per g food.
Dietary PAMP Supplementation and Oral
Gavage Experiments
For chronic PAMP treatment, WT or Il1r1−/− mice were
given ad libitum normal chow and drinking water which was
unmodified (control group), or supplemented with 100µg/ml
E. coli O111:B4 LPS, 1µg/ml Pam3CSK4, and 1µg/ml iEDAP
(D-gamma-Glu-meso-diaminopimelic acid, a component of
peptidoglycan) (PAMP group), for 8 weeks (WT mice). The
chosen TLR-stimulant concentrations are comparable with the
higher range of concentrations measured in foods (up to 28
µg Pam3CSK4-equivalent TLR2-stimulants per gram of minced
pork, and up to 10 µg E. coli LPS-equivalent TLR4-stimulants
per gram of diced onion, Figures 1A–C), when accounting for
the ∼250-fold reduced responsiveness of mice to endotoxin
compared to man (15). In experiments involving acute oral
PAMP challenge, mice were orally gavaged with 200 µl of saline
alone or containing 1mg Pam3CSK4, 1mg iEDAP, or 2mg E. coli
LPS, as described in figure legends.
Cells and Reagents
The PRR-stimulants Pam3CSK4, iEDAP and Salmonella
typhimurium flagellin were from Invivogen. E. coli O111:B4 LPS
was from Sigma. Oxidized palmitoyl arachidonyl phosphatidyl
choline (OxPAPC) was prepared by air oxidation of native PAPC
(Sigma) as described previously (16). Briefly, 1mg of PAPC in
chloroform was evaporated to dryness under nitrogen in a glass
tube. The lipid film was then exposed to air in darkness for 72 h
before resuspension to 2 mg/ml in chloroform and storage under
nitrogen at −80◦C. Aliquots of stock OxPAPC were dried under
nitrogen in microtubes immediately before use and vortexed
into pre-warmed tissue culture medium for 30 s before addition
to cells. Human embryonic kidney (HEK)-293 cells (ECACC
85120602) and HepG2 cells (ECACC 85011430) were cultured
in DMEM with 10% fetal calf serum (FCS) (Sigma). The murine
macrophage cell-lines RAW 264.7 (ECACC 91062702) and
J774A.1 (ECACC 91051511) were cultured in RPMI with 10%
FCS. Testing of cell-lines for mycoplasma contamination by PCR
revealed no such infections, and cells were routinely cultured
with Plasmocin (Invivogen) to prevent growth of mycoplasma.
Recombinant IL-1β, IL-6, and TNF-α were from Peprotech EC
Ltd. Neutralizing anti-IL-1β antibody was from R&D Systems
(AF-201-NA, used at 2 µg/ml).
Human Monocyte Culture and Challenge
Peripheral blood mononuclear cells (PBMC) were prepared
by density gradient centrifugation at 800 g for 25min using
Histopaque-1077 (Sigma). Recovered cells were washed twice in
PBS, resuspended in RPMI with 10% FCS and plated in 96-well
plates at 4 × 105 cells per well. Monocytes were prepared from
PBMC by plastic adherence (1 h at 37◦C), followed by gentle
washing to remove non-adherent cells. Remaining monocytes,
which were of∼85–90% purity as measured by CD14 staining by
flow cytometry, were then challenged by adding a 1:20 dilution
of each filter-sterilized food extract in tissue culture medium. For
inhibition of TLR2 and TLR4, OxPAPC was used at 30µg/ml, as
this has been shown previously to result in specific inhibition of
TLR2 and TLR4 signaling, but not signaling initiated via other
TLRs or cytokine receptors (17, 18). Production of TNF-α was
measured at 4 h, and IL-1β and IL-6 at 24 h, by ELISA (R&D).
Bacterial Culture and 16S Ribosomal
(r)RNA Gene qPCR
TLR-stimulant secretion was measured in conditioned
media of the following members of the food or human
commensal microbiota: Lactobacillus plantarum (NCIMB-6376),
Escherichia coli (NCTC-13114), Xanthomonas campestris (8004),
Pseudomonas fluorescens (SBW25), Pseudomonas fluorescens
(WCS365), Pectobacterium atrosepticum (ECG12), and Erwinia
chrysanthemi (EC16) were kindly provided by Dr. Rob Jackson,
University of Reading. Bacteroides fragilis (NCTC-9343) and
Bifidobacterium bifidum cells and supernatant were kind gifts of
Professor Ian Poxton (University of Edinburgh). Streptococcus
pneumoniae, Staphylococcus aureus, Pseudomonas diminuta,
Enterococcus faecalis, Pseudomonas aeruginosa, Salmonella
typhimurium were University of Strathclyde teaching laboratory
reference strains kindly provided byDavidMcNeill (University of
Strathclyde). Each strain was grown in respective standard broths
and conditions to absorbance at 600 nm of 1.0, and centrifuged
to pellet bacterial cells (13,000 g for 5min). The conditioned
medium was then filter-sterilized and stored at −20◦C prior to
assay. For 16S ribsosomal RNA (rRNA) gene qPCR, DNA was
extracted from food and stool samples using the Qiamp Stool
DNA extraction kit (Qiagen). Total historical bacterial growth
was measured by quantitative PCR using the universal 16S
rRNA gene primers 926F (AAACTCAAAKGAATTGACGG)
and 1062R (CTCACRRCACGAGCTGAC), as described
previously (19). The proteobacterial 16S rRNA gene specific
primers 1080gF (TCGTCAGCTCGTGTYGTGA) and g1202R
(CGTAAGGGCCATGATG) were then used to measure the
percentage of this total which was derived from growth of
proteobacteria. Samples were quantitated relative to an internal
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FIGURE 1 | The TLR-stimulant content of some processed foods can greatly exceed that of the normal mouse ileal microbiota. (A–C) Soluble TLR2, TLR4, and
TLR5-stimulants were quantified in processed foods (n = 14), mouse chow (n = 6), mouse ileal ingesta (n = 5), mouse feces (n = 10) and human feces (n = 6) using
HEK-293-TLR transfectants. (D-F) Pro-inflammatory cytokine production by primary human monocytes (n = 3 donors) exposed to extracts of mouse ileal ingesta,
minced meat or chocolate (n = 5 extracts of each type), diluted 1:10 (wt/vol) in culture medium. P-values vs. ileal contents, ANOVA with Tukey’s test.
standard (E. coliNCTC-13114 genomic DNA) using a Rotorgene
thermal cycler (Qiagen).
Histology and Immunohistochemistry
For histology and some immunohistochemistry experiments,
mouse tissue samples were fixed in 4% paraformaldehyde
overnight before processing to wax blocks. Five micrometers
of sections were then subjected to haematoxylin and eosin
(H&E) staining according to standard protocols. For hepatic
F4/80, TLR2 and TLR4 immunofluorescence imaging, tissue
samples were frozen immediately in optimal cutting temperature
compound (CellPath) and stored at −80◦C. Seven micrometers
of sections were then prepared using a cryostat (Leica CM3050S).
Antibodies used were rat-anti-mouse F4/80 (Abd Serotec,
MCA497GA, 1:100) with AF488-goat-anti-rat (Invitrogen, A-
11006, 1:500) or rabbit anti-rat HRP Fab’2 (Abd Serotec,
STAR21B, 1:100) secondaries. Rabbit anti-mouse TLR2 (Santa-
cruz, sc10739, 1:100) and rabbit anti-mouse TLR4 (Santa-
cruz, sc10741, 1:100) used AF594-labeled goat anti-rabbit
secondary (Invitrogen, A-11037, 1:500). Nuclei were stained
using ProLong R© Gold Antifade Reagent containing DAPI
(Invitrogen). Histological markers of intestinal inflammation
were considered to include mononuclear or polymorphonuclear
cell infiltrates, or reduced mean villus height.
ELISA and Western Blots
Serum amyloid A (SAA) was measured in mouse plasma by
ELISA (Abcam). Human and mouse IL-1β, IL-6, and TNF-
α levels were measured by respective DuoSet ELISA kits
(R&D). Western blots were probed with antibodies targeting
IL-1β (Peprotech, 500-P51, 1:1,000), ApoAI (Cell Signaling
Technology, 3350S for human, 1:250, Santa-cruz sc-30089 for
mouse, 1:250) or glyceraldehyde 3-phosphate dehydrogenase
(GAPDH, Santa-cruz, sc-25778, 1:2,000). Serum ApoAI levels
were measured by densitometry following Western blot using
ImageQuant software (GE Healthcare), and normalized to
total plasma protein, measured using the bicinchoninic acid
assay (Pierce).
Lipoprotein and Cholesterol Efflux Assays
For depletion of ApoB-containing lipoproteins from mouse
serum samples, 10 µl of 20% polyethylene glycol (PEG) in
200mM glycine buffer, pH 7.4, was added to 25 µl serum,
incubated at room temperature for 20min, then centrifuged
at 10,000 g for 30min to pellet complexed ApoB lipoproteins.
The remaining ApoB-depleted serum was used for measurement
of HDL-C (using the Amplex cholesterol assay, Invitrogen),
and serum cholesterol eﬄux capacity, which was measured
as previously described (20). Briefly, J774 macrophages were
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plated at 3 × 105 cells per well of 24-well plates and labeled
overnight with 67 kBq/mL 3H-cholesterol (Perkin-Elmer). After
equilibration for a further 6 h in DMEM containing 14mM
HEPES, cells were cultured with 500 µl eﬄux medium (MEM
containing 14mM HEPES and 0.15mM cAMP) supplemented
(or not) with 14 µl ApoB-depleted serum. After 4 h, eﬄuxed
and cell-bound cholesterol was measured by scintillation. For
measurement of functional cholesterol acceptors secreted by
HepG2 cells, 50µl of HepG2 cell conditionedmediumwas added
to 450 µl of eﬄux medium in the J774 assay. Triglycerides and
glucose levels were measured in fasted mouse serum using kits
fromWako and Invitrogen, respectively.
Measurement of LPS Translocation
LPS activity was measured in mouse plasma samples using the
Pyrochrome limulus amoebocyte lysate (LAL) assay (Associates
of Cape Cod, UK) after recovery of LPS bioactivity by heat
treatment (70◦C for 10min). LAL-activities were determined by
kinetic analysis of each reaction using a temperature controlled
microplate reader (BMG Lumistar), as previously described
(8). Serum LPS levels were below the limit of detection using
the HEK-293 TLR4 transfection assay. In some experiments,
mice were orally gavaged with 200 µl saline containing either
1mg fluorescein isothiocyanate (FITC)-LPS (Sigma), or 15mg
FITC-dextran (MWT 4 kDa, Sigma) with 2mg E. coli LPS.
FITC-LPS translocation to intestinal villi was monitored at
2.5 h by fluorescence microscopy. Percentage translocation
of FITC-dextran was quantified by fluorescence of plasma
samples collected by cardiac puncture 1.5 h after oral gavage, in
comparison with respective standard curves. For quantitation of
translocation of lumenal LPS to tissues, mice were orally gavaged
with 1mg 3H-labeled LPS in 200 µl PBS. For 3H-labeling, E.
coli cells were cultured to an optical density of 0.9 at absorbance
of 600 nm in broth supplemented with 0.74 MBq 3H-acetate
(Perkin-Elmer) per ml as previously described (21). LPS was
then extracted by the MgCl2 precipitation method as previously
described (22), yielding a specific activity of 3 kBq/mg. Organs
were extracted 4 h post-gavage, and 100mg of each tissue was
homogenized in 1ml 0.1% sodium dodecyl sulfate (SDS)/0.2M
NaOH using a bead homogeniser (Precellys). Radiolabel content
of tissue extracts was quantified by scintillation.
Priming Experiments
In experiments aiming to increase absorption of LPS from the
gut lumen, mice were fed HFD for 4 weeks, or orally gavaged
with 2 (low dose) or 10 (high dose) mg/kg indomethacin, 24 h
before oral gavage with 2mg E. coli LPS or fluorescent markers
as described above. In experiments aiming to increase in vivo
sensitivity to LPS, mice were fed HFD or high cholesterol diet
for 4 weeks before oral gavage with 2mg E. coli LPS (23,
24). Alternatively, mice fed normal chow received intravenous
injection of 200 µl normal saline containing 1mg heat-killed
(60◦C, 1 h) Propionibacterium acnes, 7 days before oral gavage
with 2mg E. coli LPS.
Clodronate Liposome Treatment
Twenty-two male C57 mice were given unrestricted access to
high fat diet (5TJN) and normal drinking water for 4 weeks.
All mice then received an intraperitoneal injection with 1mg
clodronate liposomes (www.clodronateliposomes.com) in 200 µl
saline. 72 h later, mice were orally gavaged with 200 µl PBS alone
or containing 2mg E. coli LPS (n = 11 per group). Blood was
collected by cardiac puncture 24 h after oral gavage. Liver sections
were stained for F4/80 positivity to monitor effects of clodronate
liposome treatment on hepatic macrophage number.
Flow Cytometry
For mouse primary hepatic macrophage and hepatocyte flow
cytometry, 105 cells were labeled with 4µg/ml of isotype control
antibody (rat IgG2a-PE, Cambridge Bioscience 400507, 1:50),
rat anti-mouse TLR2-PE (Cambridge Bioscience, 148603, 1:50)
or anti-TLR4-PE (Cambridge Bioscience, 145403, 1:50). For
human monocyte, PBMC and HepG2 cell-line flow cytometry,
antibodies used were AF488-labeled anti-TLR2, anti-TLR4 and
mouse IgG2a-K isotype control (eBioscience, 53-9922-41, 1:20,
53-9917-41, 1:20 & 53-4724-80, 1:50). Data were acquired using
a Gallios cytometer (Beckman Coulter).
Hepatocyte and Hepatic Macrophage
Isolation
Mouse primary hepatocytes and hepatic macrophages were
prepared by the three-step perfusion method as described
previously, (25) with the following modifications. Livers were
perfused by cannula via the vena cava and drained via the portal
vein with the following buffers in sequence: (i) 25ml clearing
medium (Hanks balanced salt solution with 0.5mM EGTA,
pH 7.4), (ii) 10ml PBS, (iii) 25ml digestion buffer [DMEM
with HEPES and 0.5 mg/ml type IV collagenase (Sigma)]. A
perfusion pump was used to regulate flow to ∼4 ml/minute
and a water bath jacket was used to maintain buffers at
37◦C during perfusion. Once the liver had swollen indicating
successful digestion of collagen, it was carefully excised, the
gall bladder removed, and cells extracted by gentle agitation
in isolation medium (ice cold DMEM with HEPES, penicillin,
streptomycin and 10% fetal calf serum). Hepatocytes and hepatic
macrophages were then isolated by the differential density
method as described previously. (25) Briefly, mixed liver cell
suspensions were centrifuged at 4◦C for 2min at 50 g. The
hepatocyte-rich pellet was resuspended in 25ml of cold isolation
medium and the centrifugation procedure was repeated twice
more (2min, 50 g washes) to further purify the hepatocytes.
Hepatocytes were then plated at 100,000 viable cells per well of
collagen coated 24-well plates, allowed to attach for 1 h at 37◦C,
and then cultured in growth medium (DMEM with 10% FCS)
overnight before use in experiments. Macrophages were collected
from the supernatant of this first wash, purified by further
centrifugations at 50 g, then plated at 80,000 viable cells per well
of non-coated 24-well plates, allowed to adhere without collagen
for 16min at 37◦C, then washed to remove residual hepatocytes,
sinusoidal and endothelial cells. Cell purity was measured by
flow cytometry for the TLR2 antigen, which was expressed by
>90% of isolated macrophages, but undetectable on hepatocytes
isolated as above. For mouse liver slice culture, livers were excised
immediately after euthanasia and tissue cylinders were prepared
using a sterilized 1 cm diameter metal punch. Circular sections of
300µm thickness were then prepared in ice-cold RPMI medium
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using a Microslicer DTK-1000 vibratome. Sections were cultured
in independent wells of 24-well plates and challenged with
PAMPs or cytokines for 24 h before measurement of cytokine
production by ELISA. Because IL-1β production was below the
limit of detection in this system, liver slice culture was not
pursued in further experiments.
Statistical Analyses
In experiments where more than two groups were compared,
one way analysis of variance (ANOVA) was performed using
Tukey’s or Dunnett’s post-test. In experiments where two
groups were compared, unpaired, two-tailed Student’s T-tests,
or the Mann–Whitney U-test, were used. Food and intestinal
PAMP concentrations were log10-transformed before analysis.
Differences were assumed to be significant at P< 0.05. Each point
plotted on categorical scatter plots corresponds to measurements
taken from independent mice. Biological rather than technical
replicates are shown throughout. Error bars shown on bar charts
are standard error of the mean (SEM). Data were analyzed using
GraphPad Prism version 7.0.
RESULTS
The PAMP Content of Some Commonly
Consumed Foods can Greatly Exceed That
of the Endogenous Murine Ileal Microbiota
Because the commensal microbiota is not evenly distributed
along the gastrointestinal tract (9), we first sought to compare
the relative biological activities of soluble stimulants of TLR2,
TLR4, & TLR5 in the ileal contents of healthy mice, with those
of murine and human stool samples, using a calibrated HEK-
293 TLR-transfection assay (26). As expected, these stimulants
were much more abundant in stool samples than in ileal contents
(Figures 1A–C). However, a screen of a selection of foods
previously identified to be at high risk of PAMP-contamination
[minced meats, diced onion, and chocolates (6)], revealed that
many of these contained TLR-stimulants at levels which were
2–3 orders of magnitude higher than normally present in the
ileum. Filter-sterilized homogenates of these foods were also
more potent inducers of pro-inflammatory cytokine production
than murine ileal contents (Figures 1D–F), and these responses
were blocked completely byOxPAPC, a specific inhibitor of TLR2
and TLR4 (Figure 2A) (17). Antibiotic treatment, or autoclaving,
prior to storage of mincedmeats also prevented the accumulation
of TLR2-stimulants in these foods, along with their capacity to
induce inflammatory cytokine production, confirming that TLR-
stimulants accumulate in these foods through the activity of
food-borne bacteria (Figures 2B,C).
We next explored how such foods may contain similar
TLR-stimulant content to the murine fecal microbiota, despite
containing lower levels of total bacterial 16S ribosome gene
DNA (rDNA) (Figure 2D). Because earlier work has identified
proteobacteria as key inducers of inflammatory signaling in the
human intestinal microbiota and during food spoilage (7, 26–28),
we quantified their historical activity in samples using viability-
independent qPCR. Meat and chocolate samples contained a
much higher proportion of proteobacterial 16S rDNA relative to
total bacterial 16S rDNA (61.9 and 14.2%), compared to mouse
or human fecal microbiota samples (2.3 and 2.4%, Figure 2E).
Conditioned media of selected proteobacteria also contained
far more abundant soluble TLR2 and/or TLR4 stimulants than
those of representative non-proteobacterial food and commensal
organisms, further supporting the notion that this group may
play a key role in determining the pro-inflammatory potential
of extracts (Figures 2F,G). Together, these findings indicate that
soluble stimulants of TLR2 and TLR4 are normally present at very
low concentrations in the healthy ileum, but can be much more
abundant in some processed foods, most likely due mainly to the
historical activity of proteobacteria.
Dietary PAMP Intake Promotes Hepatic
Inflammation and Impaired RCT
To explore the potential impact of chronic intake of dietary
PAMPs on inflammatory and metabolic markers, C57Bl/6
mice were fed normal chow for 10 weeks with or without
supplementation of drinking water with stimulants of TLR2,
TLR4 and nucleotide-binding oligomerization domain-
containing protein-1 (since NOD1-stimulants were also detected
in minced meats, Figure 2H). The chosen concentration of
lipopeptide was comparable with that measured in high-
PAMP foods (6, 7), as was that of LPS when accounting for
the ∼250-fold reduced responsiveness of mice to endotoxin
compared to man (15). Chronic dietary intake of these PAMPs
had no effect on weight gain, hepatic steatosis or a variety of
inflammatory and regulatory cytokines, key markers of T-cell
subset abundance, villus height or Paneth cell degranulation
in ileum, or histological evidence of inflammation in stomach,
ileum or colon (Figures S1A–F, S2A–K). Likewise, although
PAMP treatment increased macrophage markers in adipose
tissue (Cd68 mRNA and F4/80 protein), there was no significant
increase in expression of inflammatory cytokines (Il-1β , Il-
6, or Tnf-α) in fat (Figures S2E,H). However, a number of
markers of inflammation and the acute phase response (APR)
were upregulated in livers of PAMP-fed mice compared to
controls, consistent with a ∼6-fold increase in hepatic F4/80+
macrophages (Figures 3A,B). Although PAMP treatment did
not significantly alter homeostatic model assessment of insulin
resistance (HOMA-IR) or serum triglycerides (Figure S2D;
Figure 3C), total cholesterol was lower in serum of treated mice,
driven by significant reductions in HDL-C (Figure 3D). PAMP
treatment also reduced hepatic expression of ApoAI mRNA
and serum ApoAI protein (Figures 3B,E), and significantly
impaired the capacity of ApoB-depleted serum to accept
cholesterol eﬄuxed from macrophages—all key markers of the
RCT pathway (Figure 3F).
A Far Greater Proportion of Ingested
Endotoxin Is Absorbed Than Is Detected
by the Limulus Assay
We next aimed to quantify the fraction of ingested LPS that
may translocate to blood. Orally gavaged FITC-labeled LPS
was detectable within occasional villi post-gavage (Figure 4A),
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FIGURE 2 | The accumulation of TLR-stimulants in processed meat is dependent on the food microbiota. (A) Human primary monocytes were treated with
filter-sterilized extracts of minced meat or diced onion, 1 ng/ml E. coli LPS or 100 ng/ml Pam3CSK4, with or without oxidized palmitoyl arachidonly phosphatidyl
choline (OxPAPC, an inhibitor of TLR2 and TLR4, n = 4 volunteers). (B) NF-κB activation in HEK-293-TLR2 transfectants challenged with filter-sterilized extracts of
minced meat samples when fresh, or at the ‘best before date’ (d7), with or without treatment with the antibiotics penicillin and streptomycin (P/S), or polymyxin-B
(PMB, which specifically targets Gram-negative bacteria), or autoclaving before storage. (C) Cytokine responses of human primary monocytes to the same meat
extracts (n = 4 per group). (D) Total 16S rDNA in stool and food samples measured by qPCR (a culture-independent measure of historical bacterial activity). (E)
Proportion of proteobacterial 16S rDNA in human and mouse fecal samples and meat and chocolate samples (n = 5–7). (F) Relative biological activities of soluble
TLR2- and TLR4-stimulants in filter-sterilized conditioned media of representative proteobacterial and non-proteobacterial organisms of the food and commensal
microbiota (grown to A600 = 1.0), measured using HEK-293-TLR transfectants calibrated with Pam3CSK4 and E. coli LPS, respectively. (G) Inflammatory cytokine
production by primary human monocytes cultured with 1:1,000 dilutions of the same conditioned media. (H) NF-κB reporter responses in HEK-293 cells transfected
with NOD-1 and filter sterilized homogenates of minced meats. Error bars shown are SEM. P-values vs. control condition (medium alone), ANOVA with Dunnett’s test.
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FIGURE 3 | Chronic dietary PAMP intake induces hepatic inflammation and impairs serum cholesterol efflux capacity. WT mice (n = 8/gp) were given normal chow
and drinking water supplemented (PAMP) or not (Ctrl), with E. coli LPS, Pam3CSK4 and D-gamma-Glu-meso-diaminopimelic acid (iEDAP, a component of
peptidoglycan which stimulates NOD1), for 8 weeks. (A,B) Hepatic F4/80+ cells per field and acute phase response (APR) mRNA. (C–F) Serum homeostatic model
assessment of insulin resistance (HOMA-IR) and RCT mediators. P-values vs. control condition, Student’s T-test or ANOVA with Dunnett’s test.
but fluorescence was undetectable in blood, liver or spleen.
Measurements made using the more sensitive limulus assay,
which is traditionally used for this purpose (29), also suggested
that only a very small proportion of the dose is absorbed to
blood (∼0.00004%, assuming a mouse blood volume of 2ml and
1mg LPS ingested, Figure 4B). However, because the capacity
of LPS to stimulate the limulus assay is rapidly diminished by
blood proteins in vivo (30), we sought to measure tissue uptake
of orally delivered 3H-labeled LPS. This approach revealed that
although little or no radiolabel was detected in heart, muscle, lung
or blood post-gavage (suggesting rapid clearance of absorbed
LPS), there was significant accumulation (∼0.4% of the dose)
of 3H-LPS in liver (Figure 4C). This raised the possibility that
sufficient LPS may be absorbed from the diet to trigger the
hepatic inflammation observed in earlier experiments. However,
we found that oral delivery of the tested PAMPs, alone or
in combination, did not reproducibly induce dyslipidaemia or
hepatic inflammatory markers within 24 h in unprimed mice
(Figures S3A–G). Attempts to increase LPS absorption using
indomethacin, an established enhancer of gut permeability
(31), resulted in markedly elevated serum LPS levels post-LPS-
gavage, but hepatic APR markers were still not reproducibly
elevated, suggesting that the unprimed mouse liver displays low
responsiveness to relatively high levels of circulating LPS in
health (Figures 5A–H).
Hepatic Macrophages Mediate the APR
and Cholesterol Efflux Responses to
Dietary Endotoxin
Our efforts to develop an acute model of oral-PAMP-induced
APR for mechanistic studies therefore refocused on increasing
the sensitivity of mice to circulating LPS. Three previously
reportedmethods were employed: intraperitoneal administration
of heat-killed Propionibacterium acnes, 4 weeks priming with
high fat diet (HFD) and 4 weeks priming with high cholesterol
diet (HCD) (23, 24, 33). While all three treatments increased
hepatic macrophage number and expression of F4/80, TLR2,
and TLR4 from a low baseline, and rendered mice responsive
to orally delivered LPS within 24 h, only HFD priming
yielded a suitably low background of APR markers for
detection of hepatic inflammation in response to orally-delivered
LPS (Figures 6A–H).
In HFD-primed mice, hepatic TLR2 and TLR4 protein, APR
markers and circulating SAA were significantly increased, and
hepatic ApoAI expression, serum ApoAI, HDL-C and cholesterol
eﬄux capacity were all significantly decreased, 24 h after oral
LPS treatment (Figures 7A–G). Limulus and FITC-dextran
assays showed that this increase in responsiveness was not due
to effects of HFD on intestinal permeability (Figures 5A,B).
However, depletion of hepatic F4/80+ macrophages (by ∼98%,
Figures 8A,B) using clodronate liposomes abolished all of the
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FIGURE 4 | The absorption of ingested LPS is greatly underestimated by limulus and fluorescent assays for LPS uptake. (A) Immunofluorescence of ileal villi 90min
after gavage with saline (Ctrl) or FITC-LPS (arrow, green). (B) Serum LPS 2.5 h after oral gavage with saline alone, Pam3CSK4 or E. coli LPS, as measured using the
LAL assay (n = 4/gp). (C) Radiolabel in mouse tissues 4 h after oral gavage with 1mg 3H-labeled LPS (n = 4/gp), measured in CPM (counts per minute). P-values vs.
Ctrl (or blood levels of radiolabel for panel C), ANOVA with Dunnett’s test.
FIGURE 5 | Increased gut barrier permeability is insufficient to reproducibly increase hepatic APR markers in response to a single oral gavage with LPS. Two different
approaches were taken with to increase gut permeability and enhance translocation of LPS from gut lumen to serum: oral pre-treatment with 10 mg/kg indomethacin
(31) and 4 weeks high fat diet (HFD). (32) WT mice (n = 4/gp) were then orally gavaged with 15mg FITC-dextran and 2mg E. coli LPS in 200 µl saline. Indomethacin,
but not HFD, increased gut permeability to LPS and FITC-dextran, although with excessive background systemic inflammation (A–F). Lower dose indomethacin (2
mg/kg, n = 12/gp), resulted in a ∼14-fold increase in circulating LPS 90min post LPS-gavage, and enabled a plasma serum amyloid A (SAA) response to LPS orally
delivered later (G), but hepatic acute phase response (APR) mRNA markers were not reproducibly increased (H). Error bars shown are SEM. P-values vs. control
condition, ANOVA with Dunnett’s test.
observed responses to oral LPS (Figures 7B–G, 8C,D). Oral LPS-
induced APR was not likely secondary to cytokines released from
macrophages in the gut, vasculature or adipose tissue, since no
induction of the key APR-inducing cytokines Il-1β , Il-6, or Tnf-α
was observed in these tissues (Figures S1D, S2H; Figures 6I–K).
However, hepatic macrophages isolated from both LFD- and
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FIGURE 6 | Development of an acute murine model of oral-LPS induced APR and dyslipidaemia. Three methods previously reported to increase the sensitivity of mice
to circulating LPS were tested, (i) intraperitoneal administration of heat-killed Propionibacterium acnes (n = 6 per group), (ii) 4 weeks priming with high fat diet (HFD, n
= 10 per group) or (iii) 4 weeks priming with high cholesterol diet (HCD), (n = 12 per group) (23, 24, 33) (A) Hepatic F4/80+ve (green) cell number was significantly
elevated by all three treatments relative to control mice fed normal chow. (B) HCD and P. acnes treatment increased hepatic TLR2 and TLR4 protein expression (red)
from a very low baseline. (C) Hepatic CD68, CD14, TLR2, and TLR4 mRNA responses to each treatment. (D) Representative overlay showing co-localization of TLR2
(red) and F4/80 (green) staining, suggesting predominant expression of TLR2 on hepatic macrophages. Similar results were observed for TLR4. (E) Circulating serum
amyloid A (SAA) protein was significantly elevated by orally delivered LPS at 24 h only in HFD-primed mice—baseline SAA (a measure of the acute phase response)
was excessively raised in HCD and P. acnes primed mice. (F,G) Hepatic APR markers and apolipoprotein (Apo)-AI were not significantly increased by orally delivered
LPS in HCD and P. acnes primed mice, respectively. (H) Mice fed HFD gained significantly more body weight than mice fed normal chow. (I) 4 weeks HFD did not
significantly increase CD68 mRNA in abdominal adipose tissue. Orally delivered LPS did not induce inflammatory markers in abdominal adipose tissue (J), or aorta (K)
of HFD-primed mice within 24 h. Error bars shown are SEM. P-values vs. control condition, ANOVA with Dunnett’s test.
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FIGURE 7 | Hepatic macrophages are key mediators of the lipid and acute phase responses to ingested LPS. WT mice (n = 8–11/gp) were fed low-fat diet (LFD) or
high-fat diet (HFD) for 4 weeks, with or without treatment with clodronate liposomes to deplete tissue macrophages. (A) F4/80 (green), TLR2 and TLR4 (red)
immunofluorescence in livers of mice fed LFD or HFD for 4 weeks. (B) Hepatic acute phase response mRNA markers in saline (Ctrl) or LPS gavaged HFD-primed mice
pretreated (or not) with clodronate liposomes (CL), n = 8–11/gp. (C–G) Serum amyloid A (SAA) protein, hepatic ApoAI mRNA and serum reverse cholesterol transport
(RCT) markers in the same groups. P-values vs. control condition, ANOVA with Dunnett’s test.
HFD-fed mice produced all of these cytokines in response
to Pam3CSK4 or LPS stimulation ex vivo (Figure 8E). The
responsiveness of isolated hepatic macrophages to these stimuli
was not increased by HFD-priming, consistent with similar
levels of expression of TLR2 and TLR4 (Figures 8E,F). Taken
together, these results suggest that hepatic macrophages are key
mediators of the lipid responses to orally delivered LPS, and
that their increased abundance in the liver, rather than cellular
responsiveness to TLR-stimulants, may be a key mechanism of
HFD-induced responsiveness to orally delivered LPS.
IL-1 Is a Key Mediator of Dietary
PAMP-Mediated Downregulation of ApoAI
Since we saw no effect of acute or chronic PAMP treatment
on intestinal expression of ApoAI (Figure S1D), which accounts
for up to 30% of circulating ApoAI protein in mice (34),
we next explored the effects of PAMPs and cytokines on
cholesterol acceptors expressed by hepatocytes. IL-1β, but not
IL-6, TNF-α, or ligands of TLR2, TLR4, or NOD1 significantly
reduced ApoAI mRNA expression in human HepG2 hepatocytes
(Figures 9A,B). HepG2 cells also secrete HDL particles similar
to those found in plasma (35), and we found that the capacity
of their conditioned medium to accept cholesterol eﬄuxed from
macrophages was significantly reduced by IL-1β, but not by IL-
6, TNF-α, or TLR-stimulants directly (Figures 9C,D). This was
consistent with reduced expression of ApoAI protein by IL-1β
treatment and lack of expression of TLR2 or TLR4 protein in
these cells and mouse primary hepatocytes (Figures 9E,F). IL-
1β neutralizing antibody also reversed the inhibition of HepG2
ApoAI expression by supernatant of LPS-stimulated human
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FIGURE 8 | Isolated hepatic macrophages are sensitive to TLR2 and TLR4-stimulants. (A) Immunofluorescence (F4/80, green, DAPI, blue), showed near complete
absence of F4/80+ macrophages in liver of mice 3 days after intraperitoneal administration of 1mg clodronate liposomes (n = 8–11/gp). (B) Hepatic CD68 mRNA
was also significantly reduced by clodronate liposome (CL) treatment. (C) TNF-α production from liver slices of untreated (low-fat diet, LFD), 4 week high-fat
diet-primed (HFD), or 4 week HFD primed then CL treated (HFD+CL) mice (n = 5/gp) cultured with LPS for 24 h. (D) Serum cholesterol levels in mice primed for 4
weeks with HFD, then treated with CL, then orally gavaged with 200 µl saline alone (Ctrl) or 1mg LPS, revealed no impact of orally delivered LPS on HDL-C in these
mice (n = 11/gp). (E) Pro-inflammatory cytokine production by hepatic macrophages isolated from LFD- or HFD-primed mice treated with medium alone (Ctrl),
Pam3CSK4 or LPS (n = 3–4/gp). (F) Flow cytometry for TLR2 and TLR4 expression by RAW macrophages (positive control cell-line), in comparison with hepatic
macrophages isolated from LFD- or HFD-primed mice (representative of 3 exps). Error bars shown are SEM. Pairwise comparisons by Student’s T-test.
monocytes, suggesting a role for IL-1β in myeloid cell-induced
hepatocyte APR (Figures 9G–J).
To further explore the potential role of IL-1 in dietary PAMP
induced APR and lipid responses, we examined responses inmice
lacking the IL-1 receptor. Primary hepatocytes isolated fromWT
mice responded to supernatant of LPS-challenged WT hepatic
macrophages by reducing ApoAI mRNA, but this response
was not observed in hepatocytes isolated from Il1r1−/− mice
(Figure 10A). Likewise, although amodest SAA protein response
to orally-delivered LPS was preserved in HFD-primed Il1r1−/−
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FIGURE 9 | Interleukin-1β plays a key role in the downregulation of RCT mediators by hepatocytes in response to products secreted by activated hepatic
macrophages. (A,B) Human HepG2 hepatocytes increased serum amyloid A (SAA)-1, and reduced ApoAI, mRNA expression significantly in response to IL-1β, but
not stimulants of NOD1 (iEDAP), TLR2 (Pam3CSK4), or TLR4 (E. coli LPS). (C) Conditioned medium of HepG2 cells significantly increased the efflux of
3H-radiolabelled cholesterol from J774 macrophages. (D) The capacity of conditioned media of HepG2 hepatocytes to accept 3H-radiolabelled cholesterol effluxed
from J774 macrophages was reduced significantly by IL-1β, but not by IL-6, TNF-α, or stimulants of NOD1, TLR2, or TLR4. (E) Flow cytometry showed abundant
surface TLR2 and TLR4 on human primary monocytes, but no TLR2 and little TLR4 on HepG2 hepatocytes. Murine primary hepatocytes isolated by hepatic perfusion
also showed no expression of TLR2 or TLR4, in low-fat diet (LFD) or high-fat diet (HFD)-primed mice (representative of 4 experiments). (F) Kinetics of ApoAI protein
expression in HepG2 cells treated with IL-1β determined by Western blot. (G) HepG2 ApoAI mRNA response to conditioned medium of LPS-treated human
monocytes with isotype-control or IL-1β neutralizing antibody (n = 5 exps). (H,I) ApoAI and SAA1 mRNA responses of primary hepatocytes (isolated from n = 6
LFD-fed mice) to inflammatory cytokines (20 ng/ml). (J) ApoAI mRNA responses of primary hepatocytes (n = 3 HFD-primed mice) to indicated PAMPs (100 ng/ml).
Error bars shown are SEM. P-values vs. control condition, Student’s T-tests or ANOVA with Dunnett’s test.
mice in vivo (Figure 10B), oral LPS did not significantly alter
hepatic ApoAI mRNA, serum ApoAI protein, HDL-C or serum
cholesterol eﬄux capacity in Il1r1−/− mice (Figures 10C–F).
Interestingly, unlike bone-marrow-derived macrophages
(BMDM), isolated WT hepatic macrophages released IL-1β
protein without requirement for secondary inflammasome
stimulus, despite containing lower levels of intracellular
IL-1β protein and mRNA (Figures 10G–I). Together, these
results suggest that human and mouse hepatocytes are not
directly responsive to TLR2 or TLR4 stimulants, but may
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FIGURE 10 | Interleukin-1 is a key mediator of the lipid and acute phase responses to ingested LPS in vivo. (A) ApoAI mRNA responses of isolated wild-type (WT)
and interleukin-1 receptor deficient (Il1r1−/−) hepatocytes to conditioned medium of LPS-treated WT hepatic macrophages. (B–D) Plasma serum amyloid A (SAA),
lipoprotein cholesterol and hepatic acute phase response (APR) mRNA responses in HFD-primed Il1r1−/− mice 24 h after oral gavage with saline alone (Ctrl) or 1mg
E. coli LPS (n = 8, 10/gp). (E) ApoAI protein and efflux capacity in sera of the same mice. (F) Hepatic IL-1β mRNA in LPS-gavaged HFD-primed WT mice treated (or
not) with clodronate liposomes (CL). (G) IL-1β mRNA in LPS-treated isolated primary mouse bone marrow-derived macrophages (BMDM) and hepatic macrophages
(HM). (H) Secreted and (I), cytosolic IL-1β protein production by LPS and ATP-stimulated primary mouse BMDM and hepatic macrophages (n = 3–5/gp). P-values vs.
Ctrl, ANOVA with Dunnett’s test.
respond to orally delivered LPS via IL-1β released by activated
hepatic macrophages.
DISCUSSION
Previous studies of the mechanisms connecting microbes, innate
immune signaling and cardiometabolic risk have focused largely
on the resident intestinal microbiota (36–39). Here, we introduce
the concept that the food microbiota may also play a significant
role in this relationship, through several findings which are
unexpected in light of earlier work.
First, we show that although soluble stimulants of TLR2 and
TLR4 are abundant in the gut, they are sequestered mainly
in the large intestine, and can be orders of magnitude more
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FIGURE 11 | Suggested model for the accumulation of PAMPs in foods and their impact on APR and RCT mediators. The enrichment of the food microbiota in
proteobacterial species and their subsequent overgrowth can occur in meat and certain other food products when finely chopped and stored at or above refrigeration
temperature. This leads to the accumulation of pro-inflammatory bacterial lipopeptides and lipopolysaccharides, which retain their TLR2 and TLR4-stimulating
properties even after cooking has killed remaining viable bacteria (26). These TLR-stimulants may then be absorbed, particularly when intestinal barrier function is
impaired, to reach the portal circulation and the liver. Although hepatocytes are insensitive to these stimulants, they may be detected by hepatic macrophages, which
secrete IL-1β and other inflammatory cytokines to trigger the APR programme in hepatocytes. This results in reduced serum levels of ApoAI, which is a key mediator
of RCT and atherogenesis in mice (55). Modulation of the food microbiota therefore represents a novel potential target for the modulation of systemic inflammatory
markers and cholesterol metabolism.
abundant in some processed foods than in the healthy ileum.
At first glance, this seems counter-intuitive since the human
intestinal microbiota comprises >100 trillion bacteria and at
least 1 gram of commensal-derived LPS - both of which greatly
exceed any quantity that would likely be ingested with food
(9). However, we found that the bioactivity of LPS in the
human fecal microbiota is far lower (∼200-fold) than predicted
by numbers of Gram-negative bacteria alone (10). This low
activity is likely explained by the fact that the vast majority
(>99%) of the Gram-negative bacteria of the human large
intestine are members of the Bacteroidetes group (9, 10), which
tends to express endotoxin comprising a monophosphoryl,
penta-acyl lipid-A that does not stimulate human TLR4/MD2
(40–42). By contrast, proteobacterial species (such as E. coli)
tend to express a canonical, hexa-acyl bis-phosphorylated lipid
A, which is a potent agonist of human TLR4/MD2. The
proportionate abundance of proteobacterial 16S rDNA in the
tested foods thus helps to explain how these foods can be more
immunostimulatory than the mouse fecal microbiota, despite
containing much lower total 16S rDNA and bacterial density [up
to 1010 vs. up to 1011 CFU/g, respectively (9, 43)].
Consistent with earlier reports (14, 29), our attempts to
measure the absorption of ingested LPS using the limulus
assay suggested that the fraction which translocates to blood
is extremely small (0.00004%, Figure 4B). However, because
circulating LPS is cleared rapidly from the circulation (30), or
otherwise masked from detection by limulus enzymes through
binding to blood proteins and lipoproteins (44), we sought to
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confirm this finding using a radiolabel approach. This method
revealed that a far greater proportion of ingested LPS is absorbed
(∼0.4% to liver), than previously estimated using the limulus
assay, raising the possibility that LPS absorbed from some dietary
sources may exceed the threshold required to trigger hepatic
inflammatory signaling.
Our attempts to explore this possibility using an acute model
of LPS ingestion were based on the well-established observation
of robust acute-phase and lipid responses to intravenously
delivered LPS in mice within 24 h (15, 20). However, no such
responses were observed when LPS was administered orally to
healthy mice. Instead, some form of priming stimulus was found
to be necessary to render mice responsive to ingested LPS.
Among a number of approaches used to increase responsiveness
to LPS (23, 24, 33), HFD-priming was found to be the most
effective. This priming effect was not likely due to effects of HFD
on gut barrier permeability, since although this has been reported
to be increased by some groups (32), we and others (45, 46), did
not see this, perhaps due to differences in diet composition.
Instead, it is more likely that priming is related to hepatic
macrophage density, which was significantly increased by all
of the successful priming regimens (HFD, HCD, P. acnes
injection and chronic dietary PAMP exposure itself). This view
is supported by the observation that systemic responses to
ingested LPS were ablated in mice treated with clodronate
liposomes. Notably, although clodronate liposome treatment
depletes macrophages in diverse tissues systemically, it is
likely that hepatic macrophages, rather than macrophages in
other tissues, are the predominant mediators of the response
to dietary PAMPs in this context. For example, while key
APR-inducing cytokines were induced in liver in response to
oral LPS, they were not upregulated in other macrophage-
rich tissues, including intestinal, adipose and vascular tissues
(Figures S1D, S2H; Figures 6I–K). Also, unlike bone-marrow
derived macrophages, isolated hepatic macrophages released IL-
1β in response to LPS without requirement for priming or
secondary stimulus (Figure 8E).
Nevertheless, it should be acknowledged that hepatic
macrophages are a highly heterogeneous population, and further
work will be required to establish which functional subset is
primarily responsible for the observed effects. In particular,
it will be helpful to explore whether the response is driven
mainly by resident yolk-sac derived Kupffer cells (KCs), or
macrophages more recently recruited from the bone marrow,
both of which may stain positively for F4/80 and therefore were
not distinguished by the present study (47). Evidence suggests
that both proliferation of resident KCs and recruitment from
blood may drive the accumulation of macrophages during
liver injury, and the relative balance of these subsets may help
determine heptic responsiveness to PAMPs, since the latter are
established to elicit more inflammatory responses to PAMPs than
resident KCs (47).
Although we did not see an increase in triglyceride content
in the livers of PAMP-fed mice (Figure S2J), our findings may
offer some insight to risk factors for non-alcoholic fatty liver
disease (NAFLD), since hepatic macrophages are reported to
drive the condition in mice (48), and their density is associated
with severity of NAFLD in man (49). Markers of low-grade
inflammation, particularly those related to TLR-signaling, are
also upregulated in livers of obese patients compared to healthy
controls (50), and the condition is more common in subjects
consuming the Western diet (which is relatively high in PAMPs)
compared to theMediterranean diet (which is based more on low
PAMP foods) (51).
The induction of inflammatory cytokines and APR signaling
in the liver by ingested PAMPs could also be of potential
relevance to cardiovascular risk. Experimentally induced APR-
signaling, restricted specifically to hepatocytes, has been shown
to accelerate atherosclerosis in Apoe−/− mice (52). Several
lines of evidence also suggest that serum eﬄux capacity, and
the RCT pathway more generally, may be key regulators of
cardiovascular risk. For example, serumRCT capacity is inversely
associated with CAD risk in man (53), and protective roles have
been demonstrated for RCT and ApoAI, in murine models of
atherosclerosis (54–56). It will be interesting to explore in further
studies whether dietary PAMP intake modifies atherogenesis in
mice, or serum RCT function in man.
Our results also suggest a key role for IL-1 signaling in the
ApoAI and eﬄux responses to ingested LPS. For example, IL-
1β-neutralizing antibody blunted the suppression of hepatocyte
ApoAI expression by the conditioned media of stimulated
macrophages (Figure 9G), and responses to ingested LPS were
also blunted or absent in Il1r1−/− mice (Figures 10A–E).
Together, these findings support a model in which hepatic
macrophage-dependent sensing of food-borne PAMPs triggers a
mild APR programme in hepatocytes, driven largely via release
of IL-1β, resulting in the downregulation of ApoAI synthesis,
reduced HDL-C and impaired RCT to serum (Figure 11).
These findings offer useful new insight into the emerging
understanding that IL-1 plays a key role in the development of
both NAFLD (48) and cardiovascular disease (1). For example,
the recent CANTOS trial showed that IL-1 neutralization with
Canakinumab significantly reduced both APR markers and
cardiovascular event rate in patients with a history of myocardial
infarction (1). However, a key question raised by these studies
is what might be the source and nature of the triggers for the
IL-1 production underpinning these findings. The present study
suggests that dietary PAMPs may be a plausible candidate for IL-
1 stimulation in this context, and that IL-1 mediated reduction
in RCTmediators may be a mechanism for the protective activity
of Canakinumab.
It should be acknowledged that TLR2 and TLR4 stimulants
are well-established to trigger systemic inflammation and
dyslipidaemia when delivered at high doses intravenously (15,
20). However, it has been generally assumed to date that these
stimulants should not induce similar effects when ingested. This
view is based on the assumption that foods should contain
a far lower PAMP content than the intestinal microbiota, the
observation of no obvious deleterious phenotype (inflammatory
or otherwise) following acute oral administration of LPS or the
TLR2-stimulant Pam3CSK4 to unprimed animal models (12, 13),
the well-recognized abundance of TLR2- and TLR4-stimulants
produced by the commensal microbiota of the large intestine (10)
and the presumed low absorbance of ingested PAMPs (14, 29).
The present study provides evidence to counter each of these
assumptions for the reasons outlined above.
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If present in man, this pathway also has potential to
shed light on several key questions in dietary epidemiology.
For example, it remains unclear why the consumption of
processed meats increases risk of CAD and type II diabetes to
a greater degree than their unprocessed equivalents, which are
otherwise identical in macronutrient content (57–59). Likewise,
the mechanisms connecting processed food consumption with
systemic inflammatory markers in cross-sectional studies are
poorly defined (2, 60, 61). The present findings suggest that many
processed foods, particularly those based on minced meats, may
contain a higher PAMP content than their fresh or unchopped
equivalents, due to historical overgrowth of proteobacteria (7).
The chronic consumption of such foods could therefore impact
on markers of systemic inflammation and lipid metabolism, via
the mechanisms outlined above, as supported by the results
of our earlier dietary trials in human volunteers (8). Notably,
our findings do not suggest that commonly used probiotic
or fermentative organisms should induce similar effects, since
almost all such bacteria are Gram-positive, and as such do not
produce LPS or shed abundant stimulants of other TLRs into
their environment [Figure 2F and (26)].
In summary, we show that although the large intestine harbors
a large microbial flora, molecules released by the proteobacteria-
dominated microbiota of some processed foods may have
potential to dysregulate inflammatory and metabolic pathways
systemically when ingested. This mechanism helps to explain the
long-standing connection between processed meat intake and
metabolic disease, and introduces the food spoilage microbiota as
an unexpected potential mediator of cardiovascular risk. Further
studies are warranted to test whether cholesterol metabolism
may be modified through simple interventions targeting the food
microbiota, or their pro-inflammatory products.
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